Device Spine

Lxha

Payments companies reported to CMS as associated with Lxha. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$184Kassociated payments (2023-2025)
2clinicians with associated payments
1company reporting

By year

2023 $38K
2024 $78K
2025 $67K

Payments reported as associated with Lxha, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery of The Spine $118K
Orthopaedic Surgery $66K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Lxha

These are the largest totals companies reported as associated with Lxha. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Stephen Tolhurst Flower Mound, TX Orthopaedic Surgery of The Spine $117,910.52
Christopher Harrod Baton Rouge, LA Orthopaedic Surgery $65,733.70

Prescribed Lxha?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.